Investor

Roche Ventures

Last cheque observed May 2025. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

Growth equityQuiet

Series BSeries DSeries E

Cheques on record
0%of best year0cheques in 12 months, 9 on record
Since the last cheque528days00hrs00min00sec
Median round$50MRounds led0 of 9Mostly inUnited States, 78%
Pitch Roche Ventures

Roche Ventures highlights

  1. 01

    9 rounds on record

  2. 02

    Mostly Series B and Series D: 88% of its rounds

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first9 appearances

  1. 2025

    1 round

  2. May
    GlycoEraSeries B · CH · TechStartups$130MWith 8 others
  3. 2019

    2 rounds

  4. Mar
    Arch OncologySeries B · US · Businesswire$50MWith 3 others
  5. Mar
    MacuLogixSeries D · US · FinSMEs$39MWith 3 others
  6. 2018

    4 rounds

  7. Sept
    MinoryxSeries B · ES · FinSMEs$25MWith 9 others
  8. Jun
    SutroSeries E · US · FinSMEs$85MWith 17 others
  9. Apr
    MacrolideUS · FinSMEs$20MWith 4 others
  10. Mar
    IdeayaSeries B · US · FinSMEs$94MWith 12 others
  11. 2017

    2 rounds

  12. Nov
    SyapseSeries D · US · FinSMEs$30MWith 8 others
  13. Mar
    SutroVaxSeries B · US · FinSMEs$60MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Who they invest alongside

The investors most often in the same rounds as Roche Ventures. A count of rooms they were both in, not a relationship either has claimed.

5AM VenturesVC firm2rounds togetherAmgenCorporate VC2rounds togetherCelgeneGrowth equity2rounds togetherLongitude CapitalVC firm2rounds together

Recently backed

The latest companies Roche Ventures put money into.

GlycoEra$130M · May 2025Arch Oncology$50M · Mar 2019MacuLogix$39M · Mar 2019Sutro$85M · Jun 2018Syapse$30M · Nov 2017

Quick answers about Roche Ventures

What does Roche Ventures invest in?

Roche Ventures invests most often at Series B and Series D (88% of the rounds on record).

How active is Roche Ventures?

9 investments on record, 0 of them in the last 12 months. The most recent was in May 2025.

What has Roche Ventures invested in recently?

Its most recent investments on record: GlycoEra (Series B, May 2025), Arch Oncology (Series B, Mar 2019) and MacuLogix (Series D, Mar 2019).

How big are Roche Ventures's cheques?

The median round it joins is $50M.

Does Roche Ventures lead rounds?

Rarely, if at all: none of its 9 investments on record names it as the lead.

Where does Roche Ventures invest?

Most of the companies it backs are in the United States (78%), Switzerland (11%) and Spain (11%).

Is Roche Ventures investing now?

No investments in the last 12 months; the latest was in May 2025.

Who does Roche Ventures invest alongside?

Most often 5AM Ventures (2 rounds together), Amgen (2 rounds together) and Celgene (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it